Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin for consciousness recovery in ICU patients with brain trauma
IRCT20181104041551N3Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Aug 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of erythropoietin in traumatic brain injury (TBI) (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Level of consciousness and Deep vein thrombosis. Started Aug 2020; status: completed.
02
Drugs
erythropoietin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20181104041551N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181104041551N3.